abatacept — CareFirst (Caremark)
prophylaxis of acute graft versus host disease (aGVHD)
Initial criteria
- Member age ≥2 years
- Undergoing hematopoietic stem cell transplantation (HSCT) from a matched or 1 allele‑mismatched unrelated donor
- Medication will be used in combination with a calcineurin inhibitor (e.g., cyclosporine, tacrolimus) and methotrexate
Approval duration
1 month